Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class ASSE: 603168

Announcement on Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment